Innoviva Inc (INVA)

Return on equity (ROE)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	179,722	49,877	233,354	233,013	213,921	292,580	99,495	187,504	265,854	309,412	265,192	253,088	224,402	216,448	228,039	188,935	157,288	375,099	382,379	399,265
Total stockholders’ equity	US$ in thousands	674,955	627,493	555,087	561,493	565,788	641,368	388,337	386,642	414,743	402,811	329,780	634,461	539,912	485,556	456,907	379,543	313,495	267,055	226,683	188,245
ROE		26.63%	7.95%	42.04%	41.50%	37.81%	45.62%	25.62%	48.50%	64.10%	76.81%	80.41%	39.89%	41.56%	44.58%	49.91%	49.78%	50.17%	140.46%	168.68%	212.10%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $179,722K ÷ $674,955K
= 26.63%

Innoviva Inc's return on equity (ROE) has exhibited variability over the past eight quarters, ranging from 7.95% to 48.50%. The lowest ROE of 7.95% was recorded in Q3 2023, indicating a relatively weaker performance in generating profits from shareholders' equity during that period. On the other hand, the highest ROE of 48.50% was achieved in Q1 2022, reflecting a strong ability to generate returns on equity for shareholders in that quarter.

Overall, the ROE trend shows fluctuations, with some quarters performing exceptionally well, such as Q1 2022 and Q2 2022, while others showing a weaker performance, like Q3 2023. It is important for investors and analysts to closely monitor the ROE trend to assess the company's efficiency in utilizing its equity to generate profits and create value for shareholders.